] . 2010. “The Design Of Phase Ii Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations From The Clinical Trial Design Task Force Of The National Cancer Institute Investigational Drug Steering Committee.”. Clin Cancer Res 16 (6). Clin Cancer Res: 1764-9. doi:10.1158/1078-0432.CCR-09-3287.
. 2018. “The Current Understanding Of The Endocrine Effects From Immune Checkpoint Inhibitors And Recommendations For Management.”. Jnci Cancer Spectr 2 (3). Jnci Cancer Spectr: pky021. doi:10.1093/jncics/pky021.